Sign Up to like & get
recommendations!
0
Published in 2021 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2021.1964470
Abstract: ABSTRACT Introduction: Cholangiocarcinomas (CCA) are rare tumors that are associated with a variety of molecular alterations. Many of these alterations are now actionable using drugs currently in development, and CCA may be a perfect example…
read more here.
Keywords:
development cca;
oncology;
molecular alterations;
clinical trials ... See more keywords